The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT ...

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding ...

Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...